Showing 1 - 10 of 13
The global pharmaceutical sector is highly patent intensive, and firms rely on product, process and formulation patents to protect their innovations. Intellectual property rights on pharmaceutical products, as contained in the Agreement on Trade Related Aspects of Intellectual Property Rights...
Persistent link: https://www.econbiz.de/10010856343
The Indian pharmaceutical industry is presently going through a phase of transition and potential consolidation, owing to India's new TRIPS-compliant intellectual property regime and other rules aimed at enhancing the industry's credibility nationally and internationally. Appropriate policy...
Persistent link: https://www.econbiz.de/10010856422
The impact of patent protection on biomedical innovation has been a controversial issue. Although a "medical anti-commons" has been predicted due to a proliferation of patents on upstream technologies, evidence to test these concerns is only now emerging. However, most industrial surveys that...
Persistent link: https://www.econbiz.de/10010712264
The impact of patent protection on biomedical innovation has been a controversial issue. Although a “medical anti-commons” has been predicted due to a proliferation of patents on upstream technologies, evidence to test these concerns is only now emerging. However, most industrial surveys...
Persistent link: https://www.econbiz.de/10010712400
The focus of this paper is to find an operative definition of traditional knowledge for purposes of drug research and development. Starting out with the international debate on Art. 8(j) of the Convention on Biological Diversity, 1993 and the Agreement on Trade Related Aspects of Intellectual...
Persistent link: https://www.econbiz.de/10010712408
The focus of this paper is to find an operative definition of traditional knowledge for purposes of drug research and development. Starting out with the international debate on Art. 8(j) of the Convention on Biological Diversity, 1993 and the Agreement on Trade Related Aspects of Intellectual...
Persistent link: https://www.econbiz.de/10005297687
The impact of patent protection on biomedical innovation has been a controversial issue. Although a “medical anti-commons” has been predicted due to a proliferation of patents on upstream technologies, evidence to test these concerns is only now emerging. However, most industrial surveys...
Persistent link: https://www.econbiz.de/10005795729
The impact of patent protection on biomedical innovation has been a controversial issue. Although a "medical anti-commons" has been predicted due to a proliferation of patents on upstream technologies, evidence to test these concerns is only now emerging. However, most industrial surveys that...
Persistent link: https://www.econbiz.de/10005150790
The global pharmaceutical sector is highly patent intensive, and firms rely on product, process and formulation patents to protect their innovations. Intellectual property rights on pharmaceutical products, as contained in the Agreement on Trade Related Aspects of Intellectual Property Rights...
Persistent link: https://www.econbiz.de/10005150821
The Indian pharmaceutical industry is presently going through a phase of transition and potential consolidation, owing to India's new TRIPS-compliant intellectual property regime and other rules aimed at enhancing the industry's credibility nationally and internationally. Appropriate policy...
Persistent link: https://www.econbiz.de/10005150874